Advertisements

Folinic Acid

Quick links to important sections

Folinic Acid

Advertisements
Advertisements

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Folinic Acid

What is Folinic Acid?

Folinic acid, also known as leucovorin, is a medication used to manage and treat the effects of certain medications that interfere with folic acid metabolism. It is a reduced form of folic acid and belongs to the class of medications known as folic acid analogues.

Mechanism and Function

Folinic acid does not require the enzyme dihydrofolate reductase to be converted into its active form within the body. This allows it to bypass specific metabolic blocks created by certain medical treatments. In the body, it serves as a source of thymidine and purines, which are essential components for DNA synthesis and cellular repair.

Clinical Applications

Folinic acid is primarily utilized in two distinct clinical contexts:

  • Reduction of Toxicity: It is used to limit the side effects of medications that act as folic acid antagonists. By providing a source of active folate, it helps protect healthy cells from the systemic effects of these treatments.
  • Enhancement of Efficacy: In certain therapeutic regimens, folinic acid is administered alongside other agents to stabilize the binding of those agents to their target enzymes, thereby increasing the effectiveness of the primary treatment.

Relationship to Folic Acid

While closely related to folic acid (Vitamin B9), folinic acid is metabolically distinct. Because it is already in a reduced state, it is more readily available for use by cells when the normal conversion process of dietary folic acid is impaired. It is not used as a general nutritional supplement but rather as a specific pharmacological intervention.

Advertisements

What side effects are possible with Folinic Acid?

Possible Side Effects and Safety Information

The safety profile of Folinic Acid (Leucovorin) is structured around its use as a rescue agent and its potentiation of other medications. When Folinic Acid is used as a single agent (monotherapy), documented adverse reactions are generally uncommon or rare, primarily affecting specific body systems.


Official Regulatory Classifications

Side effects are officially classified by frequency and system-organ class in regulatory documents:

System-Organ Class Rare Adverse Reactions (Less than 0.1%) Uncommon Adverse Reactions (0.1% to 1%)
Nervous System Seizure, Syncope —
Psychiatric Disorders Insomnia, Agitation, Depression (linked to high doses) —
General Disorders — Pyrexia (Fever, after injection)
Immune System Hypersensitivity, Anaphylactic Reaction —

Serious adverse reactions, though infrequent, include Anaphylactic Shock (a severe allergic reaction) and life-threatening Neurotoxicity if the medication is administered via the contraindicated intrathecal (intraspinal) route.


Key Safety Constraints and Population Notes

The most significant safety information is linked to its use in combination with chemotherapy, specifically 5-fluorouracil (5-FU), where Folinic Acid is documented to enhance the toxicity of 5-FU. This potentiation can lead to severe and potentially fatal gastrointestinal effects, such as enterocolitis and dehydration, particularly in elderly patients.

Furthermore, regulatory documents strictly prohibit the use of Folinic Acid for treating megaloblastic anemia if the underlying cause is a Vitamin B12 deficiency, as this can mask the blood-related symptoms while allowing irreversible neurological damage to advance.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documentation indicates that Folinic Acid (Leucovorin Calcium) possesses low acute and chronic toxicity in humans. Regulatory records note that no adverse effects were observed in adults following prolonged ingestion of high daily doses. Therefore, an oral overdose of the active substance itself is not typically associated with severe symptoms.

However, the regulatory profile mandates urgent attention for specific administration route errors or procedural misuse that constitute acute overdose situations. Administration of Folinic Acid via the intrathecal route is strictly forbidden and is officially documented as a severe risk that may be harmful or fatal. Additionally, the intravenous solution, Leucovorin Calcium, must be infused slowly; an injection rate exceeding 160 mg per minute creates the risk of hypercalcemia due to the formulation's calcium content, requiring immediate control.

In the event of a suspected drug overdose or administration error, regulatory guidance requires individuals to immediately contact their regional poison control centre for the most current management information. No specific antidote is documented for an overdose of Folinic Acid. A specific population consideration is noted: the medication may increase the frequency of seizures in susceptible children.

Advertisements

Therapeutic Uses of Folinic Acid

Main Uses and Therapeutic Benefits

Folinic acid, also known as leucovorin, is a chemically reduced form of folic acid. While it is related to the vitamin folate, it does not require the same enzymatic conversion by the body, allowing it to be utilized more directly in various clinical settings.

Management of Folate Antagonist Effects

The primary use of folinic acid is to manage the effects of medications that act as folate antagonists. Certain treatments work by blocking the enzyme dihydrofolate reductase, which prevents the body from using folic acid. Folinic acid provides a source of reduced folate that bypasses this blockage, helping to protect healthy cells and tissues. This process is often referred to as biochemical rescue.

Potentiation of Fluorouracil

In specific therapeutic protocols, folinic acid is used to increase the effectiveness of fluorouracil. Rather than acting as a rescue agent in this context, folinic acid stabilizes the binding of fluorouracil to its target enzyme within cells. This synergy enhances the activity of the treatment against certain types of rapidly dividing cells, particularly in the gastrointestinal tract.

Treatment of Folate Deficiency

Folinic acid is utilized to treat megaloblastic anemia when the condition is caused by a deficiency of folate and oral folic acid supplementation is not sufficient or appropriate. It helps restore normal red blood cell production by providing the necessary folate metabolites required for DNA synthesis.

Key Benefits

  • Cellular Protection: By providing a direct source of active folate, it helps mitigate the systemic impact of certain high-dose medications on healthy marrow and mucosal cells.
  • Efficiency: Because it is already in a reduced form, it remains effective even when the body's ability to convert standard folic acid is impaired.
  • Enhanced Efficacy: It acts as a biochemical modulator that can improve the performance of specific co-administered treatments.

Regulatory References

  1. NIH MedlinePlus overview
Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Folinic Acid?

Folinic Acid (Leucovorin Calcium) eligibility is determined by strict rules in official regulatory documents, defining specific groups who must not use the medicine and those who require conditional use.


Official Contraindications

Classification Population Restriction
Absolute Contraindication Patients with known hypersensitivity to the drug or any excipients. The intrathecal administration route is prohibited.
Comorbidity Exclusion Patients with pernicious anemia or other megaloblastic anemias caused by Vitamin B12 deficiency.

Conditional Use and Restrictions

Age-Related Rules: Use is established in adults and for specific pediatric indications, such as methotrexate rescue. Safety and effectiveness are not established for all pediatric uses. Older adults, especially when receiving combination therapy with 5-fluorouracil, require special consideration due to an increased risk of severe toxicity.

Physiological/Condition Status: Use in pregnancy requires a clinical benefit-risk assessment by a physician. The use of the combination regimen with 5-fluorouracil is not recommended for women who are breastfeeding. Patients with renal impairment or those taking certain anti-epileptic drugs require careful monitoring.

Advertisements

What should I know about interactions with other medicines?

Folinic Acid Interactions with other medicines and products

The official regulatory profile for Folinic Acid (Leucovorin) documents specific drug–drug interactions, co-administration restrictions, and population-based cautions.


The use of Folinic Acid is contraindicated in patients with pernicious anemia or other megaloblastic anemias resulting from a Vitamin B12 deficiency. This is due to the potential to mask the hematological symptoms while allowing associated severe neurological damage to progress.

A major documented interaction involves Fluorouracil (5-FU). Folinic Acid enhances the toxicity of 5-FU, leading to an increased risk of severe gastrointestinal toxicities. Due to chemical incompatibility, Folinic Acid and 5-FU must not be mixed in the same intravenous injection or infusion solution. This combination also carries a heightened risk of severe gastrointestinal toxicity in elderly or debilitated patients.

Folinic Acid may also affect the action of other medications. As a folate derivative, it can reduce the therapeutic efficacy of Folic Acid Antagonists, such as Trimethoprim and Pyrimethamine. Additionally, Folinic Acid can impact the plasma concentrations of certain antiepileptic substances, including Phenobarbital and Phenytoin, by increasing their hepatic metabolism. This interaction is officially described as potentially leading to a counteraction of the antiepileptic effect and an increase in the frequency of seizures.

Advertisements

Mechanism of Action

Bypassing Metabolic Blocks and Restoration of Cofactor Supply

Folinic Acid (Leucovorin) acts through a highly specific mechanism by supplying a pre-activated reduced folate derivative that bypasses the need for the Dihydrofolate Reductase (DHFR) enzyme. It is readily transported into the cell via the Reduced Folate Carrier (RFC) to immediately provide the necessary cofactors for the one-carbon metabolism pathway. This substrate replacement mechanism restores the ability of healthy, rapidly dividing cells to continue the synthesis of DNA and RNA components, leading to the maintenance of DNA repair and replication in these high-turnover cell populations.

Mechanism of Enzyme Inhibition Enhancement

In its second role, Folinic Acid's active form, 5,10- methylenetetrahydrofolate (5,10- CH2 -THF), acts as a structural cofactor to enhance the effect of certain other medications, specifically 5-Fluorouracil ( 5-FU). The cofactor physically locks the 5-FU metabolite onto the enzyme Thymidylate Synthase (TS), forming a highly stable ternary complex . This synergistic stabilization results in sustained, profound inhibition of TS activity, driving molecular interference in the synthesis of DNA building blocks in the target cell.

Advertisements

Dosage and Administration Information

Administration Overview

Folinic acid is available in several formulations, including oral tablets and injectable solutions. The method of administration is determined by the specific clinical objective and the primary treatment it is supporting.

Oral Administration

When taken by mouth, folinic acid is absorbed through the digestive tract. It is typically recommended to take the tablets with a full glass of water. The presence of food generally does not significantly alter the absorption of the medication, though consistency in how it is taken relative to meals is often suggested to maintain stable levels in the body.

Injectable Administration

In clinical settings, folinic acid may be administered via intravenous (IV) infusion or intramuscular (IM) injection. This route is often utilized when higher concentrations are required or when the patient is unable to tolerate oral medication. Injectable forms are prepared and administered by healthcare professionals to ensure the correct technique and timing.

Timing and Coordination

The timing of folinic acid administration is a critical factor in its effectiveness. It is frequently used as part of a sequenced protocol alongside other medications.

  • Sequential Use: In many therapeutic regimens, folinic acid must be administered at precise intervals following the primary medication to achieve the desired metabolic support.
  • Consistency: Maintaining a regular schedule helps ensure that the concentration of the substance remains within the intended therapeutic range.

Storage and Handling

Proper storage is essential to maintain the stability of the medication:

  • Tablets: Should be stored at room temperature, away from excessive heat, moisture, and direct light. The container should be kept tightly closed when not in use.
  • Injectables: Vials are typically stored under refrigeration or as directed by the specific product labeling until they are prepared for use. Once reconstituted, the solution has a limited stability window and must be used or discarded according to professional standards.
Advertisements

Recent Clinical Evidence

Evidence for Folinic Acid as a Rescue Agent in High-Dose Methotrexate Protocols

Folinic Acid has been widely studied for its role in mitigating the effects of high-dose methotrexate (HDMTX), which is known to create systemic physiological strain. Research has been conducted using controlled clinical studies and retrospective analyses involving both adult and pediatric patients with various cancers. The primary research examined outcomes related to severe events like bone marrow suppression and the development of mucositis or severe diarrhea.

Studies described patterns where the timely use of Folinic Acid was associated with differences in the measurement of these acute outcomes in the observed populations. Because this rescue function is an established standard of care, limited new comparative evidence is lacking. Recent research often focuses on optimizing the timing and exact dose rather than reconfirming the primary rescue effect.

Studies on Folinic Acid's Combination Use with 5-Fluorouracil (5-FU)

Folinic Acid was evaluated in combination with the chemotherapy agent 5-Fluorouracil (5-FU) in large-scale Randomized Controlled Trials (RCTs) involving adult patients with advanced colorectal cancer. These studies were designed to explore the outcomes of the two agents administered together compared to 5-FU administered alone.

Trials reported differences in survival measurements (such as Overall Survival and Progression-Free Survival) and Tumor Response Rates compared to single-agent 5-FU protocols. Findings were often mixed across different early trials, indicating that observed patterns were highly dependent on the specific schedule and infusion methods used. Data for long-term outcomes specific to Folinic Acid’s function in maintenance are still limited outside of the primary study endpoints.

Key Studies & References

  1. Folinic Acid - StatPearls - NCBI Bookshelf (Review on indications, including megaloblastic anemia and rescue)
  2. Drug-Drug Interactions of Irinotecan, 5-Fluorouracil, Folinic Acid and Oxaliplatin and Its Activity in Colorectal Carcinoma Treatment - MDPI
  3. Megaloblastic Anemia: What It Is, Symptoms, Causes & Treatment - Cleveland Clinic (Source for deficiency background and outcomes)
Advertisements

Frequently Asked Questions (FAQ)

Common questions about Folinic Acid (FAQ)


Q: How long does it typically take to feel the effects of Folinic Acid?

A: Folinic Acid is a medication used in time-critical rescue protocols. When administered intravenously, the active form of the substance generally reaches its highest concentration in the blood within approximately 10 minutes, according to regulatory data. The clinical duration of the rescue protocol is determined by monitoring how the body processes the primary medication.


Q: Can Folinic Acid cause stomach upset or diarrhea?

A: Regulatory documents indicate that when Folinic Acid is used alone, gastrointestinal issues like stomach upset and diarrhea are rare. However, when used in combination with the chemotherapy agent 5-fluorouracil (5-FU), official product information notes that gastrointestinal toxicities, including diarrhea and nausea, are expected and can be serious.


Q: Is it normal to feel nausea after taking Folinic Acid?

A: Nausea is not a commonly reported side effect when Folinic Acid is used by itself. Its occurrence is more commonly noted when the medicine is administered in combination with the chemotherapy agent 5-fluorouracil (5-FU), as indicated in official regulatory data.


Q: Can I take Folinic Acid with pain relievers like ibuprofen?

A: Official product information on drug interactions focuses primarily on other prescription medications. It suggests informing your healthcare professional about all other medications you are taking, including non-prescription pain relievers like ibuprofen.


Q: Does alcohol affect how Folinic Acid works?

A: Specific warnings about alcohol use are not routinely detailed on the official product labels for Folinic Acid. The official product information suggests informing your healthcare professional about your alcohol consumption while on this medication.


Q: How should Folinic Acid be stored?

A: Folinic Acid (Leucovorin) requires careful handling. Official storage instructions state that oral tablets and unopened vials of the injectable form must be kept at controlled room temperature, typically between 20 C and 25 C (68 F to 77 F). The medication must be protected from light and kept safely out of the sight and reach of children.


Q: Is it safe to take Folinic Acid with other vitamin supplements?

A: The use of Folinic Acid is strictly contraindicated (prohibited) in patients who have megaloblastic anemia caused by a Vitamin B12 deficiency. This is because providing folate without B12 can mask the blood-related symptoms while allowing neurological damage to worsen. This regulatory warning underscores the need for professional guidance before combining Folinic Acid with any other vitamin or supplement.


Q: Can I stop taking Folinic Acid suddenly?

A: Folinic Acid is not a simple, fixed daily dose medication; its use is part of a time-critical clinical protocol. Because the treatment duration is determined by clinical monitoring and laboratory testing, adjustments to the medication schedule should only be made by a healthcare professional.


Q: Can Folinic Acid affect sleep?

A: Yes, according to official regulatory data, disturbances to sleep can occur. Insomnia (difficulty sleeping) is listed as a rare adverse reaction, meaning it occurs in less than 0.1% of patients.


Q: Can Folinic Acid be used for conditions other than cancer treatment?

A: Yes, Folinic Acid has other regulatory indications beyond its use as a rescue agent in chemotherapy. Official documents also approve its use for the treatment of megaloblastic anemias caused by a deficiency of folic acid, in cases where oral therapy is not considered appropriate.


Q: Is a skin rash a common side effect of Folinic Acid?

A: Official reports classify skin rash as a rare side effect, meaning it is not a common occurrence. Hypersensitivity (allergic reaction) is also listed as a rare adverse event, and severe allergic reactions are possible, though infrequent.


Q: Does Folinic Acid have a role in mental health or mood?

A: Official regulatory product information lists specific psychiatric issues as potential rare side effects, occurring in less than 0.1% of patients. These effects, typically linked to high doses, include agitation and depression.


Q: Are there different strengths of Folinic Acid available?

A: Yes, Folinic Acid (Leucovorin) is available in different strengths to meet varied clinical needs, as noted in public regulatory information. It is prepared in both oral tablets and sterile solutions for injection.


Q: How quickly is Folinic Acid eliminated from the body?

A: Official pharmacokinetic studies describe the elimination of the active form of Folinic Acid. The active substance has a relatively quick half-life of approximately 32 to 35 minutes. The total terminal half-life of the active components is about 6 hours.


Q: Is there a risk of allergic reaction to Folinic Acid?

A: Yes, there is a known risk. Official documents list severe hypersensitivity (allergy) to the product as a contraindication. Anaphylactic reaction (a severe, life-threatening allergic response) and hypersensitivity are classified as rare adverse reactions.


Q: Why is it important to take Folinic Acid exactly as directed by a doctor?

A: Official warnings emphasize that taking the medication exactly as prescribed is critical because the dosage and timing are dependent on the levels of the primary medication. Deviating from the schedule may impact the effectiveness of the treatment protocol.


Q: Is Folinic Acid used to treat folate deficiency directly?

A: Yes, in addition to its use as a rescue agent, Folinic Acid is officially indicated for the treatment of megaloblastic anemias caused by a deficiency of folic acid. This medicine is indicated for use in cases where oral therapy is not considered appropriate.

Advertisements

How should Folinic Acid be stored and disposed of?

How to Store and Dispose of Folinic Acid

Official regulatory guidelines strictly define the storage and handling of Folinic Acid (Leucovorin Calcium).


Storage Conditions

Unopened vials and tablets must be stored at controlled room temperature, typically 20 C to 25 C (68 F to 77 F), and must be protected from light and excessive heat.

Storage Restriction Requirement
Freezing Do not freeze the product.
Container Store in the original container.
Child Safety Keep out of the sight and reach of children.

Stability and Disposal

Reconstituted or diluted solutions for injection have limited stability, often requiring use within 12 to 24 hours, with the specific time dependent on whether the solution is refrigerated or kept at room temperature. Unused, expired, or leftover Folinic Acid must be disposed of strictly in accordance with local requirements for pharmaceutical waste.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Folinic Acid found in:

A-Z Index: